Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127184791 | 12718479 | 1 | I | 201607 | 20160831 | 20160906 | 20160906 | EXP | US-PFIZER INC-2016413566 | PFIZER | 44.00 | YR | F | Y | 46.72000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127184791 | 12718479 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 3X/DAY (20MG 1 TABLET THREE TIMES A DAY) | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||||
| 127184791 | 12718479 | 2 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | 160 UG, 2X/DAY (80 MCG 2 PUFFS 2 TIMES A DAY) | 0 | 160 | UG | BID | ||||||||
| 127184791 | 12718479 | 3 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | 0 | ||||||||||||
| 127184791 | 12718479 | 4 | C | BUMEX | BUMETANIDE | 1 | Oral | UNK UNK, DAILY (1-2MG BY MOUTH DAILY) | 0 | ||||||||||
| 127184791 | 12718479 | 5 | C | TUMS | CALCIUM CARBONATE | 1 | 200MG 2 TABLETS DAILY AS NEEDED | 0 | TABLET | ||||||||||
| 127184791 | 12718479 | 6 | C | OSCAL D | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 500 MG, 2X/DAY (500MG 1 TABLET TWICE A DAY) | 0 | 500 | MG | TABLET | BID | |||||||
| 127184791 | 12718479 | 7 | C | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 70 NANOGRAMS/KG/MIN CONTINUOUS INTRAVENOUS | 0 | ||||||||||
| 127184791 | 12718479 | 8 | C | NEURONTIN | GABAPENTIN | 1 | 300 MG, 3X/DAY | 0 | 300 | MG | TID | ||||||||
| 127184791 | 12718479 | 9 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 2 MG, UNK (2MG BY MOUTH EVERY 4 HOURS AS NEEDED) | 0 | 2 | MG | ||||||||
| 127184791 | 12718479 | 10 | C | ALDACTONE | SPIRONOLACTONE | 1 | UNK UNK, 1X/DAY (25MG HALF A TABLET ONCE A DAY) | 0 | TABLET | QD | |||||||||
| 127184791 | 12718479 | 11 | C | WARFARIN | WARFARIN | 1 | 2.5MG 0.5 TO 2 TABLETS AS DIRECTED | 0 | TABLET | ||||||||||
| 127184791 | 12718479 | 12 | C | OXYGEN. | OXYGEN | 1 | 10 LITERS NASAL CANNULA CONTINUOUS AT HOME | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127184791 | 12718479 | 1 | Pulmonary hypertension |
| 127184791 | 12718479 | 2 | Dyspnoea |
| 127184791 | 12718479 | 3 | Chronic respiratory failure |
| 127184791 | 12718479 | 4 | Oedema |
| 127184791 | 12718479 | 5 | Dyspepsia |
| 127184791 | 12718479 | 6 | Mineral supplementation |
| 127184791 | 12718479 | 7 | Pulmonary hypertension |
| 127184791 | 12718479 | 8 | Pain |
| 127184791 | 12718479 | 9 | Pain |
| 127184791 | 12718479 | 10 | Oedema |
| 127184791 | 12718479 | 11 | Coagulopathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127184791 | 12718479 | HO |
| 127184791 | 12718479 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127184791 | 12718479 | Cardiac failure | |
| 127184791 | 12718479 | Cardiac failure congestive | |
| 127184791 | 12718479 | Chronic respiratory failure | |
| 127184791 | 12718479 | Condition aggravated | |
| 127184791 | 12718479 | Dyspnoea | |
| 127184791 | 12718479 | Hypoxia | |
| 127184791 | 12718479 | Pneumonia | |
| 127184791 | 12718479 | Pulmonary hypertension | |
| 127184791 | 12718479 | Pyrexia | |
| 127184791 | 12718479 | Respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127184791 | 12718479 | 1 | 2008 | 20160827 | 0 |